CoChat

A Countrywide Survey of hrp2/3 Deletions and kelch13 Mutations Co-occurrence in Ethiopia

Kamaliddin, Claire, Burke-Gaffney, Jack, Ashraf, Shoaib, Castañeda-Mogollón, Daniel, Adamu, Aderaw, Mekonen Tefa, Bacha, Wijesinghe, Ayesha, Pussegoda, Enaara, Feleke, Sindew Mekasha, Pillai, Dylan R · 2024 · The Journal of Infectious Diseases
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Malaria elimination relies on detection of Plasmodium falciparum histidine-rich proteins 2/3 (HRP2/3) through rapid diagnostic tests (RDTs) and treatment with artemisinin combination therapies (ACTs). Data from the Horn of Africa suggest increasing hrp2/3 gene deletions and ACT partial resistance kelch13 (k13) mutations. To assess this, 233 samples collected during a national survey from 7 regions of Ethiopia were studied for hrp2/3 deletions with droplet digital polymerase chain reaction (ddPCR) and k13 mutations with DNA sequencing. Approximately 22% of the study population harbored complete hrp2/3 deletions by ddPCR. Thirty-two of 44 of k13 single-nucleotide polymorphisms identified were R622I associated with ACT partial resistance. Both hrp2/3 deletions and k13 mutations associated with ACT partial resistance appear to be co-occurring, especially in Northwest Ethiopia. Ongoing national surveillance relying on accurate laboratory methods are required to elaborate the genetic diversity of P. falciparum.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiae373

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 35

  1. World Health Organization, 2022, World malaria report 2022
  2. Venkatesan, 2024, The 2023 WHO world malaria report, Lancet Microbe, 5, e214, 10.1016/S2666-5247(24)00016-8 · DOI · Paper page
  3. Gamboa, 2010, A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests, PloS One, 5, e8091, 10.1371/journal.pone.0008091 · DOI · Paper page
  4. Beshir, 2022, Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed, Malar J, 21, 201, 10.1186/s12936-022-04226-2 · DOI
  5. Jejaw Zeleke, 2022, Plasmodium falciparum histidine-rich protein 2 and 3 genes deletion in global settings (2010–2021): a systematic review and meta-analysis, Malar J, 21, 26, 10.1186/s12936-022-04051-7 · DOI
  6. Stabler, 2022, Gene coverage count and classification (GC3): a locus sequence coverage assessment tool using short-read whole genome sequencing data, and its application to identify and classify histidine-rich protein 2 and 3 deletions in Plasmodium falciparum, Malar J, 21, 357, 10.1186/s12936-022-04376-3 · DOI
  7. Dafalla, 2020, Kelch 13-propeller polymorphisms in Plasmodium falciparum from Jazan region, southwest Saudi Arabia, Malar J, 19, 397, 10.1186/s12936-020-03467-3 · DOI
  8. Noedl, 2008, Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, 359, 2619, 10.1056/NEJMc0805011 · DOI · Paper page
  9. Ariey, 2014, A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, 505, 50, 10.1038/nature12876 · DOI · Paper page
  10. Asua, 2021, Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda, J Infect Dis, 223, 985, 10.1093/infdis/jiaa687 · DOI · Paper page
  11. Uwimana, 2020, Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda, Nat Med, 26, 1602, 10.1038/s41591-020-1005-2 · DOI · Paper page
  12. Lopez, 2021, Systematic review of Plasmodium falciparum and Plasmodium vivax polyclonal infections: impact of prevalence, study population characteristics, and laboratory procedures, PloS One, 16, e0249382, 10.1371/journal.pone.0249382 · doi:10.1371/journal.pone.0249382
  13. Feleke, 2021, Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia, Nat Microbiol, 6, 1289, 10.1038/s41564-021-00962-4 · DOI · Paper page
  14. Golassa, 2020, High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia, PloS One, 15, e0241807, 10.1371/journal.pone.0241807 · DOI
  15. Molina-de la Fuente, 2022, Deletion patterns, genetic variability and protein structure of pfhrp2 and pfhrp3: implications for malaria rapid diagnostic test in Amhara region, Ethiopia, Malar J, 21, 287, 10.1186/s12936-022-04306-3 · DOI
  16. Rogier, 2022, Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions from persons with symptomatic malaria infection in Ethiopia, Kenya, Madagascar, and Rwanda, Emerg Infect Dis, 28, 608, 10.3201/eid2803.211499 · DOI · Paper page
  17. Mihreteab, 2023, Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea, N Engl J Med, 389, 1191, 10.1056/NEJMoa2210956 · DOI · Paper page
  18. World Health Organization, 2020, Template protocols to support surveillance and research for pfhrp2/pfhrp3 gene deletions
  19. Baker, 2005, Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests, J Infect Dis, 192, 870, 10.1086/432010 · DOI · Paper page
  20. Vera-Arias, 2022, High-throughput Plasmodium falciparum hrp2 and hrp3 gene deletion typing by digital PCR to monitor malaria rapid diagnostic test efficacy, Elife, 11, e72083, 10.7554/eLife.72083 · DOI
  21. Mohon, 2014, Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009–2013), Malar J, 13, 431, 10.1186/1475-2875-13-431 · DOI
  22. Menegon, 2017, Identification of Plasmodium falciparum isolates lacking histidine-rich protein 2 and 3 in Eritrea, Infect Genet Evol, 55, 131, 10.1016/j.meegid.2017.09.004 · DOI
  23. Girma, 2019, Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: a cross-sectional study, Clin Infect Dis, 69, 1003, 10.1093/cid/ciy1005 · DOI
  24. Bayih, 2016, A unique Plasmodium falciparum K13 gene mutation in northwest Ethiopia, Am J Trop Med Hyg, 94, 132, 10.4269/ajtmh.15-0477 · DOI · Paper page
  25. World Health Organization, 2023, WHO Malaria Policy Advisory Group (MPAG) meeting report, 18–20 April 2023
  26. De Laurent, 2018, Polymorphisms in the K13 gene in Plasmodium falciparum from different malaria transmission areas of Kenya, Am J Trop Med Hyg, 98, 1360, 10.4269/ajtmh.17-0505 · DOI
  27. Liang, 2019, Inhibition of heme sequestration of histidine-rich protein 2 using multiple epitope-targeted peptides, J Pept Sci, 25, e3203, 10.1002/psc.3203 · doi:10.1002/psc.3203
  28. Yang, 2020, Disruption of Plasmodium falciparum histidine-rich protein 2 may affect haem metabolism in the blood stage, Parasit Vectors, 13, 611, 10.1186/s13071-020-04460-0 · DOI
  29. Birnbaum, 2020, A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites, Science, 367, 51, 10.1126/science.aax4735 · DOI · Paper page
  30. Xie, 2020, K13, the cytostome, and artemisinin resistance, Trends Parasitol, 36, 533, 10.1016/j.pt.2020.03.006 · DOI
  31. Klonis, 2011, Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion, Proc Natl Acad Sci U S A, 108, 11405, 10.1073/pnas.1104063108 · DOI · Paper page
  32. Nair, 2022, Fitness costs of pfhrp2 and pfhrp3 deletions underlying diagnostic evasion in malaria parasites, J Infect Dis, 226, 1637, 10.1093/infdis/jiac240 · doi:10.1093/infdis/jiac240
  33. Watson, 2017, Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa, Elife, 6, e25008, 10.7554/eLife.25008 · DOI
  34. Siddiqui, 2017, Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin-resistant Plasmodium falciparum, J Infect Dis, 215, 1435, 10.1093/infdis/jix156 · DOI
  35. Castañeda-Mogollón, 2023, Amplicon deep sequencing reveals multiple genetic events lead to treatment failure with atovaquoneproguanil in Plasmodium falciparum, Antimicrob Agents Chemother, 67, e0170922, 10.1128/aac.01709-22 · doi:10.1128/aac.01709-22

Cited by

See all 24

Metadata

Authors
Kamaliddin, C., Burke-Gaffney, J., Ashraf, S., Castañeda-Mogollón, D., Adamu, A., Mekonen Tefa, B., Wijesinghe, A., Pussegoda, E., Feleke, S. M., & Pillai, D. R.
Affiliations
  • Departments of Pathology & Laboratory Medicine, Medicine, and Microbiology, Immunology and Infectious Diseases, University of Calgary , Calgary, Alberta ,
  • Department of Bacteriology, Parasitology, and Zoonoses, Ethiopia Public Health Institute , Addis Ababa ,
  • Undergraduate Studies, University of Western Australia , Perth ,
Venue
The Journal of Infectious Diseases
Published
2024-07-31
Volume
230
Issue
6
Pages
e1394-e1401
ISSN
  • 0022-1899
  • 1537-6613
Cited by
24
References
2
Language
en
Funders
  • University of Calgary
  • Grand Challenges Canada
  • Ethiopian Public Health Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Countrywide Survey of hrp2/3 Deletions and kelch13 Mutations Co-occurrence in Ethiopia. https://app.cochat.ai/papers/10.1093/infdis/jiae373
The paper
Kamaliddin, C., Burke-Gaffney, J., Ashraf, S., Castañeda-Mogollón, D., Adamu, A., Mekonen Tefa, B., Wijesinghe, A., Pussegoda, E., Feleke, S. M., & Pillai, D. R. (2024). A Countrywide Survey of hrp2/3 Deletions and kelch13 Mutations Co-occurrence in Ethiopia. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae373

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.